Dopexamine: much more than a vasoactive agent.
Bennett
E D
ED
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002199:Capillary Permeability / Q000187:drug effects; D004195:Disease Models, Animal; D004298:Dopamine / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D007962:Leukocytes / Q000187:drug effects; D051379:Mice; D051381:Rats; D018805:Sepsis / Q000188:drug therapy* / Q000276:immunology*; D013552:Swine; D014665:Vasodilator Agents / Q000494:pharmacology*
D000318:Adrenergic beta-Agonists; D000893:Anti-Inflammatory Agents; D014665:Vasodilator Agents; C046318:dopexamine; D004298:Dopamine